liver impairment
Recently Published Documents


TOTAL DOCUMENTS

159
(FIVE YEARS 37)

H-INDEX

18
(FIVE YEARS 2)

Mycoses ◽  
2021 ◽  
Author(s):  
Tobias Lahmer ◽  
Paula M. Peçanha‐Pietrobom ◽  
Roland M Schmid ◽  
Arnaldo Lopes Colombo

Metabolites ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 618
Author(s):  
Georgios Stavropoulos ◽  
Kim van Munster ◽  
Giuseppe Ferrandino ◽  
Marius Sauca ◽  
Cyriel Ponsioen ◽  
...  

Liver diseases are currently diagnosed through liver biopsy. Its invasiveness, costs, and relatively low diagnostic accuracy require new techniques to be sought. Analysis of volatile organic compounds (VOCs) in human bio-matrices has received a lot of attention. It is known that a musty odour characterises liver impairment, resulting in the elucidation of volatile chemicals in the breath and other body fluids such as urine and stool, which may serve as biomarkers of a disease. Aims: This study aims to review all the studies found in the literature regarding VOCs in liver diseases, and to summarise all the identified compounds that could be used as diagnostic or prognostic biomarkers. The literature search was conducted on ScienceDirect and PubMed, and each eligible publication was qualitatively assessed by two independent evaluators using the SANRA critical appraisal tool. Results: In the search, 58 publications were found, and 28 were kept for inclusion: 23 were about VOCs in the breath, one in the bile, three in urine, and one in faeces. Each publication was graded from zero to ten. A graphical summary of the metabolic pathways showcasing the known liver disease-related VOCs and suggestions on how VOC analysis on liver impairment could be applied in clinical practice are given.


2021 ◽  
pp. 556-566
Author(s):  
Alexandra Shingina ◽  
Anne M. Larson

The development of jaundice, ascites, or encephalopathy in the context of chronic liver disease or malignancy is an ominous indicator of advanced disease. In two studies of individuals admitted to hospital with jaundice, up to 42% of patients with malignancy and up to 23% with cirrhosis died during their first admission. The necessity of a willingness to adopt a ‘palliative approach’ to the care of such individuals is obvious. This chapter discusses three features of liver impairment that may be encountered in those for whom palliative care is appropriate.


Medicina ◽  
2021 ◽  
Vol 57 (6) ◽  
pp. 597
Author(s):  
Bianca Cerbu ◽  
Stelian Pantea ◽  
Felix Bratosin ◽  
Iulia Vidican ◽  
Mirela Turaiche ◽  
...  

Background and Objectives: The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at greater risk for complications and poor outcomes. The objective of this study was to investigate the liver function abnormalities and clinical outcomes in patients with COVID-19 and chronic hepatitis C. Materials and Methods: This retrospective, single-center study was conducted on a cohort of 126 patients with a history of hepatitis C, confirmed with COVID-19 between 01 April 2020 and 30 December 2020. Several clinical outcomes were compared between patients with active and non-active HCV infection, and the risks of liver impairment and all-cause mortality in active HCV patients were analyzed using a multivariate logistic regression model. Results: Among 1057 patients under follow-up for chronic HCV infection, 126 (11.9%) were confirmed with COVID-19; of these, 95 (75.4%) were under treatment or achieved SVR, while in the other 31 (24.6%), we found active HCV replication. There was a significantly higher proportion of severe COVID-19 cases in the active HCV group as compared to the non-active HCV group (32.2 vs. 7.3%, p < 0.001). Multivariate analysis showed that age, sex, alanine aminotransferase, C-reactive protein, procalcitonin, and HCV viral load were significant independent risk factors for liver impairment and all-cause mortality. The length of stay in hospital and intensive care unit for COVID-19 was significantly higher in patients with active HCV infection (p-value < 0.001), and a higher proportion of these patients required mechanical ventilation. Conclusions: Active HCV infection is an independent risk factor for all-cause mortality in COVID-19 patients.


2021 ◽  
Vol 27 (15) ◽  
pp. 1531-1552
Author(s):  
Fares E M Ali ◽  
Zuhair M Mohammedsaleh ◽  
Mahmoud M Ali ◽  
Osama M Ghogar

2021 ◽  
pp. 1-2
Author(s):  
Mansi. Makwana ◽  
Jaydev Mod

We report the case of a 20 year old male who came to the hospital because of jaundice and a fever. His symptoms were associated with signicant liver impairment and a necroinammatory pattern due to viral hepatitis B although he had no relevant medical history. His symptoms developed rapidly until death. We present the factors that may have inuenced his progression to fulminant liver failure as described in the literature.


Sign in / Sign up

Export Citation Format

Share Document